Hyewon Ryu
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 26
- Chemokine receptors and signaling 7
-
- Gallbladder and Bile Duct Disorders 7
- Co-authors
- Hyo Jin Lee (29 shared papers)Il Hwan Kim (10 shared papers)Jaekyung Cheon (9 shared papers)Changhoon Yoo (10 shared papers)Baek‐Yeol Ryoo (8 shared papers)Ik‐Chan Song (24 shared papers)Kyu‐pyo Kim (9 shared papers)Jae Ho Jeong (7 shared papers)
- Journals
- Medicine (6 papers)Cancer Research and Treatment (5 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Scientific Reports (2 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Hyewon Ryu
57 papers receiving 606 citations
Peers
Comparison fields: 5 of 84
- Oncology 245
- Internal Medicine 17
- Pulmonary and Respiratory Medicine 146
- Surgery 196
- Genetics 44
Countries citing papers authored by Hyewon Ryu
This map shows the geographic impact of Hyewon Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyewon Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyewon Ryu more than expected).
Fields of papers citing papers by Hyewon Ryu
This network shows the impact of papers produced by Hyewon Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyewon Ryu. The network helps show where Hyewon Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hyewon Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 135 | |
| 2 | 2023 | 42 | |
| 3 | 2018 | 26 | |
| 4 | Decursin inhibits cell growth and autophagic flux in gastric cancer via suppression of cathepsin C. | 2021 | 22 |
| 5 | 2021 | 21 | |
| 6 | Decursin inhibits tumor growth, migration, and invasion in gastric cancer by down-regulating CXCR7 expression. | 2019 | 21 |
| 7 | 2019 | 20 | |
| 8 | 2015 | 18 | |
| 9 | 2020 | 18 | |
| 10 | 2017 | 17 | |
| 11 | 2017 | 17 | |
| 12 | 2021 | 16 | |
| 13 | 2021 | 16 | |
| 14 | 2017 | 16 | |
| 15 | 2022 | 16 | |
| 16 | 2020 | 16 | |
| 17 | 2021 | 15 | |
| 18 | 2018 | 14 | |
| 19 | 2022 | 13 | |
| 20 | 2020 | 12 |
About Hyewon Ryu
Hyewon Ryu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Genetics, having authored 65 papers that have together received 614 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Eosinophilic Disorders and Syndromes (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Gallbladder and Bile Duct Disorders (7 papers), Chemokine receptors and signaling (7 papers), Palliative Care and End-of-Life Issues (7 papers), Cancer Genomics and Diagnostics (6 papers) and Patient Dignity and Privacy (6 papers). The work is most often cited by research in Oncology (245 citations), Internal Medicine (17 citations), Pulmonary and Respiratory Medicine (146 citations), Surgery (196 citations) and Genetics (44 citations). Hyewon Ryu has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Hyo Jin Lee, Il Hwan Kim, Jaekyung Cheon, Changhoon Yoo, Baek‐Yeol Ryoo, Ik‐Chan Song, Kyu‐pyo Kim, Jae Ho Jeong, Myoung Joo Kang and Ji Sung Lee. Their work appears in journals such as Medicine, Cancer Research and Treatment, Journal of Clinical Oncology, Annals of Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.